Can you buy vaginal estrogen over the counter?
In the United States, low-dose vaginal estrogen is a prescription treatment, and it is not sold over the counter. What you can buy without a prescription are nonhormonal vaginal moisturizers and lubricants. For milder symptoms of genitourinary syndrome of menopause (GSM), the genital and urinary changes once grouped under the term vaginal atrophy, those nonhormonal products are the recommended first-line option and a reasonable place to start.
What you can buy over the counter
Two kinds of nonhormonal products sit on the shelf without a prescription. Moisturizers are used on a regular schedule, roughly daily to every two or three days, or one to three times a week, to keep the vaginal tissue hydrated over time. They mimic normal vaginal secretions but do not reverse the underlying tissue changes of GSM. Lubricants come in water, silicone, and oil-based forms and are used at the time of sex for short-term comfort. When choosing among them, water-based and silicone-based products are generally well tolerated and latex-safe, while oil-based lubricants can erode condoms, and it helps to avoid additives like glycerin, parabens, and propylene glycol that can irritate sensitive tissue. Both moisturizers and lubricants are recommended as first-line therapy: nonhormone lubricants with sexual activity and long-acting vaginal moisturizers. For most women with mild symptoms, nonhormonal therapy provides enough relief, so this is a sensible place to start. They can also be continued alongside a prescription therapy, so buying them is not wasted effort.
What needs a prescription
The FDA-approved vaginal estrogen products are prescription therapies. They come as creams, either estradiol or conjugated estrogens, as tablets or inserts, and as a vaginal ring, and all of these forms are acceptable choices. All of the approved products have proven efficacy in placebo-controlled trials and work with similar effect, so the decision among them is mostly about fit and preference. Vaginal estrogen is a local, low-dose therapy: systemic absorption is minimal, and serum estradiol stays within the postmenopausal range. It is the preferred hormonal treatment when nonprescription measures are not enough, and it reliably relieves dryness and painful sex, though full benefit usually takes one to three months. When symptoms are moderate to severe, or when moisturizers and lubricants stop being enough, these prescription options are effective treatments. Two other prescription-only treatments also exist for GSM: vaginal DHEA (prasterone) inserts and ospemifene, an oral medication. None of these can be bought over the counter.
Natural estrogen creams are not the same
Products marketed as natural estrogen cream, or as plant-based phytoestrogen creams, are not the same as prescription vaginal estrogen, and they are not evidence-based. In a one-year randomized trial, black cohosh, a multi-botanical supplement, and soy produced no change in vaginal dryness and no change in estradiol levels. Herbal and supplement products have not been shown to relieve GSM, and none of those studied raised estradiol. No over-the-counter vitamin or supplement replaces the estrogen the tissue is missing.
Why the prescription step is worth it
Needing a prescription is not only a hurdle. GSM is a clinical diagnosis, and a clinician confirms it by matching your symptoms to the examination findings and ruling out conditions that can mimic it, such as a vulvar skin disorder, contact dermatitis, or infection. Any vaginal bleeding after menopause needs its own evaluation before it is attributed to dryness, because spotting or bleeding in a postmenopausal woman calls for a thorough workup. A clinician also helps match the formulation, cream, insert, or ring, to your preference, since the approved products work similarly and the choice comes down to what fits your routine.
References
- Faubion SS, Sood R, Kapoor E. Genitourinary Syndrome of Menopause: Management Strategies for the Clinician. Mayo Clinic Proceedings. 2017. doi:10.1016/j.mayocp.2017.08.019
- Faubion SS, Kingsberg SA, Clark AL, et al. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020. doi:10.1097/GME.0000000000001609
- Ringel NE, Iglesia C. Common Benign Chronic Vulvar Disorders. American Family Physician. 2020.
← Learn more about Vaginal Estrogen